Cart summary

You have no items in your shopping cart.

Syrosingopine

SKU: orb1219310

Description

Syrosingopine has selective depleting effect on brain amines is potentiated by combined treatment with disulfiram or fusaric acid, a dopamine beta-hydroxylase inhibitor.The anticancer activity of the widely used diabetic drug metformin is strongly potentiated by Syrosingopine. Synthetic lethality elicited by combining the two drugs is synergistic and specific to transformed cells. This effect is unrelated to Syrosingopine s known role as an inhibitor of the vesicular monoamine transporters. Syrosingopine binds to the glycolytic enzyme α±-enolase in vitro, and the expression of the γ-enolase isoform correlates with nonresponsiveness to the drug combination. Syrosingopine sensitized cancer cells to metformin and its more potent derivative phenformin far below the individual toxic threshold of each compound.

Images & Validation

Key Properties

CAS Number84-36-6
MW666.71
Purity>98% (HPLC)
FormulaC35H42N2O11
SMILES[H][C@@]12C(NC3=C4C=CC(OC)=C3)=C4CCN1C[C@]5(C[C@@H](OC(C6=CC(OC)=C(OC(OCC)=O)C(OC)=C6)=O)[C@H](OC)[C@@H](C(OC)=O)[C@]5(C2)[H])[H]
TargetDopamine Receptor
SolubilityDMSO:62.5 mg/mL (93.74 mM; Need ultrasonic)

Bioactivity

In Vivo
Animal model: Spontaneously hypertensive rats (SHR) (2 to 17-month-age). Dosage: 5 mg/kg. Administration: Subcutaneous injection; once (16 hours before undertaking the study of blood pressure). Result: Showed anti-hypertensive activity by depleting peripheral stores of norepinephrine.
In Vitro
Cell Viability Assay Cell line: HeLa, MCT1-KO, MCT4-KO HAP1, HAP1 MCT1-KO. Concentration: 10 μM. Incubation time: 1, 2, 3, 4 hours. Result: Caused intracellular lactate accumulation and acidification. Slowed lactate efflux by inhibiting MCT4 and MCT1. Induced synthetic lethality by inhibiting transport of lactate when combined with metformin.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Syrosingopine [orb1297197]

    99.60%

    84-36-6

    666.71

    C35H42N2O11

    1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Syrosingopine (orb1219310)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

200 mg
500 mg
5 mg
$ 220.00
10 mg
$ 320.00
25 mg
$ 520.00
50 mg
$ 760.00
100 mg
$ 1,040.00